Weaver C. Barksdale & Associates’s Hanover Insurance THG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$30K Hold
276
0.03% 125
2017
Q3
$27K Sell
276
-19
-6% -$1.81K 0.03% 130
2017
Q2
$26K Buy
295
+11
+4% +$946 0.03% 135
2017
Q1
$26K Sell
284
-29
-9% -$2.57K 0.03% 135
2016
Q4
$28K Hold
313
0.05% 131
2016
Q3
$24K Buy
313
+49
+19% +$3.89K 0.04% 136
2016
Q2
$22K Buy
264
+31
+13% +$2.67K 0.04% 124
2016
Q1
$21K Sell
233
-25
-10% -$2.06K 0.02% 160
2015
Q4
$21K Sell
258
-11
-4% -$910 0.02% 155
2015
Q3
$21K Sell
269
-47
-15% -$3.72K 0.02% 154
2015
Q2
$23K Sell
316
-10
-3% -$718 0.02% 155
2015
Q1
$24K Buy
326
+25
+8% +$1.77K 0.02% 152
2014
Q4
$21K Sell
301
-54
-15% -$3.65K 0.02% 161
2014
Q3
$22K Buy
355
+23
+7% +$1.43K 0.02% 152
2014
Q2
$21K Sell
332
-12
-3% -$729 0.02% 161
2014
Q1
$21K Buy
344
+15
+5% +$878 0.02% 165
2013
Q4
$20K Sell
329
-29
-8% -$1.71K 0.02% 181
2013
Q3
$20K Sell
358
-31
-8% -$1.65K 0.02% 188
2013
Q2
$19K Buy
+389
New +$19.1K 0.02% 184

Other funds holding THG

Weaver C. Barksdale & Associates's THG Position: Q4 2017 in Review

Weaver C. Barksdale & Associates held its Hanover Insurance (THG) position steady in Q4 2017 at 276 shares worth $30K. The position accounts for 0.03% of the portfolio, ranked #125.

Weaver C. Barksdale & Associates first reported a position in THG in Q2 2013 and has held it in 19 quarters since. 297 funds tracked by Wall St. Rank hold THG as of Q4 2017.

  • Weaver C. Barksdale & Associates held 276 shares of Hanover Insurance worth $30K as of Q4 2017.
  • Weaver C. Barksdale & Associates left its Hanover Insurance share count unchanged in Q4 2017.
  • Hanover Insurance made up 0.03% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #125 holding.
  • Weaver C. Barksdale & Associates first reported a position in Hanover Insurance in Q2 2013 and has held it in 19 quarters since.
  • 297 funds tracked by Wall St. Rank held Hanover Insurance as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.